CNK1 and other scaffolds for Akt/FoxO signaling  by Fritz, Rafael D. & Radziwill, Gerald
Biochimica et Biophysica Acta 1813 (2011) 1971–1977
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamcrReview
CNK1 and other scaffolds for Akt/FoxO signaling☆
Rafael D. Fritz a, Gerald Radziwill b,⁎
a Department of Biomedicine, Institute of Biochemistry and Genetics, University of Basel, Mattenstrasse 28, CH-4058 Basel, Switzerland
b Centre for Biological Signalling Studies BIOSS, Faculty of Biology, University of Freiburg, Schaenzlestrasse 1, D-79104 Freiburg, GermanyAbbreviations: CNK, connector enhancer of KSR; F
glycogen synthase kinase; IGF-1, insulin-like growth fa
kinase; MST1, mammalian sterile 20-like kinase 1; NE
nuclear localization signal; PI3K, phosphatidylinositol-3
modiﬁcation; SGK, serum- and glucocorticoid-induced k
☆ This article is part of a Special Issue entitled: P13K-AKT
⁎ Corresponding author. Tel.: +49 761 203 2635; fax
E-mail addresses: rafael.fritz@unibas.ch (R.D. Fritz),
gerald.radziwill@bioss.uni-freiburg.de (G. Radziwill).
0167-4889/$ – see front matter © 2011 Elsevier B.V. Al
doi:10.1016/j.bbamcr.2011.02.008a b s t r a c ta r t i c l e i n f oArticle history:
Received 15 December 2010
Received in revised form 1 February 2011
Accepted 5 February 2011
Available online 12 February 2011
Keywords:
Posttranslational modiﬁcation
Proliferation
Scaffold
Signaling
TumorigenesisFoxO transcription factors mediate anti-proliferative and pro-apoptotic signals and act as tumor suppressors
in cancer. Posttranslational modiﬁcations including phosphorylation and acetylation regulate FoxO activity by
a cytoplasmic–nuclear shuttle mechanism. Scaffold proteins coordinating signaling pathways in time and
space play a critical role in this process. CNK1 acts as a scaffold protein in several signaling pathways
controlling the function of FoxO proteins. An understanding of CNK1 and other scaffolds in the FoxO signaling
network will provide insights how to release the tumor suppressor function of FoxO as a possibility to block
oncogenic pathways. This article is part of a Special Issue entitled: P13K-AKT-FoxO axis in cancer and aging.oxO, Forkhead box O; GSK3,
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The FoxO (Forkhead box O) class of transcription factors is
evolutionally highly conserved and composed of four members in
mammalians: FoxO1, FoxO3a, FoxO4 and FoxO6. FoxO transcription
factors promote cell cycle arrest and apoptosis as well as detoxiﬁca-
tion of reactive oxygen species and repair of damaged DNA. Thereby,
mammalian FoxO proteins support tumor suppression and extend
lifespan [1]. In addition, FoxO proteins regulate energy metabolism by
enhancing gluconeogenesis. FoxO proteins consist of four regions: a
N-terminal highly conserved DNA-binding domain, a nuclear locali-
zation signal (NLS), a nuclear export signal (NES) and a C-terminal
transactivation domain. While all FoxO proteins share a common
DNA-binding domain, other domains may be more speciﬁc for the
unique members as revealed by knockout and transgenic mouse
studies (reviewed in [2]). FoxO1, FoxO3a and FoxO4 are ubiquitously
expressed, although to different levels in different tissues, whereas
expression of FoxO6 seems to be restricted to the brain [3,4]. Activity
of FoxO proteins is negatively regulated mainly by sequestering these
proteins in the cytoplasm in cells treated with survival or growth
factors [5,6]. In addition, change in level of FoxO proteins can occur by
increased proteasomal degradation [7]. On the other side, FoxOactivity is positively affected by increased expression and mRNA
stability as well as chromosomal rearrangements resulting in fusion of
the FoxO transactivation domain to DNA-binding domains of other
transcription factors. Fusions of Pax3 and Pax7 with FoxO1 are found
in rhabdomyosarcomas, whereas MLL is fused to FoxO3 or FoxO4 in
mixed-lineage leukemia [8–10].
Posttranslational modiﬁcations (PTMs) are an important mecha-
nism regulating FoxO activity in both directions. FoxO phosphoryla-
tion by Akt and serum- and glucocorticoid-induced kinase (SGK) leads
to cytoplasmic sequestration or proteasomal degradation of FoxO
proteins. This effect is counteracted by the kinase mammalian sterile
20-like kinase 1 (MST1) and the c-Jun N-terminal kinase (JNK) both of
which phosphorylate FoxO proteins speciﬁcally [11,12]. Acetylation
reduces the DNA-binding capacity of FoxO proteins and enhances Akt-
dependent phosphorylation of FoxO1 [13]. In addition, monoubiqui-
tination induces nuclear localization and transcriptional activation as
shown for FoxO4 [14]. These examples illustrate the interplay
between different types of PTMs in regulation of FoxO activity.
Scaffold proteins gain more and more importance as regulators of
signal transduction processes. Scaffold proteins are multidomain
proteins most often without an enzymatic function. They play an
essential role in the organization of signaling processes in time and
space and are responsible for proper and efﬁcient signal propagation
within signaling cascades. The emphasis of this review lies on recent
ﬁndings on the function of scaffolds in regulating FoxO activity.2. Scaffold proteins in FoxO signaling
The main regulatory step for FoxO activity is a shuttle mechanism,
which conﬁnes FoxO proteins either to the nucleus or to the
1972 R.D. Fritz, G. Radziwill / Biochimica et Biophysica Acta 1813 (2011) 1971–1977cytoplasm. Akt and the related kinase SGK directly phosphorylate
FoxO1, FoxO3a, and FoxO4 at three regulatory sites (Thr24, Ser256
and Ser319 in human FoxO1 sequence), thereby creating binding sites
for 14-3-3 proteins. Binding of 14-3-3 to FoxO in the nucleus induces a
conformational change in FoxO proteins, which expose their NES for
interaction with Exportin/Crm1 [6]. In addition, 14-3-3 masks the
FoxO NLS and bothmechanisms lead to the retention of FoxO proteins
in the cytoplasm [5]. Reversible acetylation provides a further
regulatory mechanism for FoxO proteins [15]. CBP/p300 directly
binds and acetylates FoxO in its forkhead DNA-binding-domain
thereby reducing its ability to interact with target DNA [13,16].
Sirt1, a member of a family of nicotinamide adenine dinucleotide
(NAD)-dependent protein deacetylases called sirtuins, binds to and
deacetylates FoxO proteins at lysine residues that are acetylated by
CBP/p300 [17,18]. Thus, Sirt1 positively controls FoxO activity. Both
posttranslational mechanisms, i.e. phosphorylation/dephosphoryla-
tion and acetylation/deacetylation, are targets for regulation of FoxO
activity by scaffold proteins.
A typical scaffold regulating FoxO signaling is the nuclear vitamin D
receptor (VDR). VDR mediates the interaction of deacetylases and
phosphatases with their substrate FoxO in the nucleus [19] (Fig. 1, top
left). Upon stimulation of cells with vitamin D (1,25-dihydroxyvitamin
D – 1,25D), the ligand-bound VDR associates directly with nuclear
FoxO3a and FoxO4 on the one hand and the deacetylase Sirt1 and the
catalytic subunit of protein phosphatase 1 (PP1) on the other hand.Fig. 1. Regulation of FoxO activity by nuclear and cytoplasmic scaffold proteins. The vitamin D
Sirt1 and the phosphatase PP1 in order to activate FoxO (green) and to induce gene expressio
2.1, which deacetylates DAF-16/FoxO and restores downstream gene expression (top right).
inactivation of FoxO by Akt-dependent phosphorylation (bottom left). The C. elegans scaffol
signaling involving AKT-1/2 on the one hand and the activation of JNK-1 by its upstream ac
stimulate its transcriptional activity (bottom right).1,25D-induced FoxO deacetylation and dephosphorylation block the
nuclear export of FoxO, consistent with FoxO activation. Whether the
VDR scaffold associates only with activated Sirt1 and PP1 or also
regulates their enzymatic activity is still an open question. Nevertheless,
VDR can counteract the inactivation of FoxO proteins primed by
acetylation and phosphorylation [13]. Thus, FoxO proteins are key
downstream mediators of the anti-proliferative action of 1,25D.
In general, 14-3-3 proteins are negative regulators of FoxO activity
by sequestering FoxO in the cytoplasm in growth factor stimulated
cells [20]. However in Caenorhabditis elegans, an additional function of
14-3-3 proteins has been described ([21,22], Fig. 1, top right). Under
stress conditions 14-3-3 acts as a nuclear scaffold that bridges DAF-
16/FoxO and the deacetylase SIR-2.1, which is the ortholog of Sirt in
mammalians, forming a ternary complex. This elicits the DAF-16/
FoxO-dependent expression of genes involved in stress resistance and
life span extension [21,22].3. Function of scaffolds in the PI3K-Akt-FoxO axis
The ﬁrst identiﬁed and primary regulatory signal for FoxO
transcription factors is the phosphatidylinositol-3 kinase (PI3K)/Akt
signaling pathway that responds to insulin and insulin-like growth
factor 1 (IGF-1) and several other growth factors [5]. Akt-dependent
phosphorylation of FoxO proteins results in binding to 14-3-3receptor assembles an acetylated and phosphorylated FoxO (red) with the deacetylase
n (top left). In C. elegans, a 14-3-3 dimer bridges DAF-16/FoxO with the deacetylase SIR-
The cytoplasmic scaffold protein ProF binds simultaneously Akt and FoxO leading to the
d SHC-1 activates DAF-16/FoxO through the suppression of the DAF-2/insulin receptor
tivator kinase MEK-1 on the other hand. Both pathways converge on DAF-16/FoxO and
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of FoxO-regulated gene expression.
Recently, the propeller FYVE (ProF) protein was identiﬁed as a
scaffold protein for FoxO1 during adipogenesis [23]. FoxO1 is highly
expressed in adipose tissue and a negative regulator of insulin
signaling and adipogenesis [24]. ProF consists of seven WD (trypto-
phan-aspartic acid dipeptide) repeats forming a putative β-propeller
and a FYVE (Fab1p, YOTB, Vac1p and EEA1) domain. Cytoplasmic ProF
interacts with Akt and FoxO and mediates Akt-dependent phosphor-
ylation of FoxO at Ser253, which is located in the Forkhead DNA-
binding domain (Fig. 1, bottom left). By inactivating FoxO activity,
ProF is a positive regulator of insulin-induced adipogenesis and
increases the glucose uptake in differentiated cells [23].
SHC-1/p52Shc is a scaffold that targets both insulin/IGF-1 and JNK
signaling pathways to modulate life span and stress response in C.
elegans [25] (Fig. 1, bottom right). Loss of SHC-1 accelerates aging and
enhances sensitivity to heat, oxidative stress and heavy metals. SHC-1
represses insulin/IGF-1 function by directly interacting with the
receptor DAF-2, the ortholog of the insulin/IGF-1 receptor in
mammals. Moreover SHC-1 activates JNK signaling by binding to its
activator MEK-1 kinase. Thus, SHC-1 coordinates the activity of two
parallel pathways to increase FoxO's nuclear localization and activity
and thereby to allow normal stress response and prolonged life span
in C. elegans.
4. The scaffold CNK1 in Akt/FoxO signaling
Recently, we identiﬁed the scaffold protein connector enhancer of
KSR 1 (CNK1) as a critical regulator of oncogenic signaling in breast
cancer cells [26,27]. CNK1-driven proliferation relies on Akt-dependent
phosphorylation and inactivation of FoxO proteins. Thus, CNK1 is a
novel regulator of Akt/FoxO signaling in both normal and cancer cells
[27].
4.1. Domain structure and expression of CNK proteins
CNK proteins are evolutionarily conserved scaffold proteins essential
for different signaling pathways. Five isoforms are expressed in
mammals, namely CNK1, CNK2A/MAGUIN-1 (membrane-associated
guanylate kinase-interacting protein-1) and its splice form CNK2B/
MAGUIN-2, CNK3A as well as CNK3B/IPCEF1 (interaction protein for
cytohesin exchange factors 1) (Fig. 2). CNK3A and CNK3B correspond to
the N-terminal and C-terminal parts of CNK, respectively [28]. They are
encodedby twodifferent loci on the samemouseorhumanchromosome
and no overlapping transcripts have been detected so far. In contrast to
mammals, the model organisms Drosophila melanogaster and C. elegans
express only one CNK isoformmost homologous to mammalian CNK2A
(Fig. 2, [29]).
According to their role as scaffolds, CNK proteins contain several
interaction domains (Fig. 2). The N-terminal part of CNK harbors a
sterile alpha motif (SAM), a conserved region in CNK (CRIC) and a
PSD-95/DLG-1/ZO-1 (PDZ) domain. The C-terminal portion of CNK
consists of a pleckstrin homology (PH) domain and polyproline
sequences. CNK1 contains a unique proline-rich region that spans
about 90 amino acids instead of polyproline sequences. Mammalian
CNK2A, CNK2B and CNK3A contain an additional conserved region
that was identiﬁed by the protein families (Pfam) database and
named domain of unknown function 1170 (DUF1170). Potential
coiled-coil regions were detected in CNK1, CNK2A and CNK2B. The C-
terminal regions of CNK1, CNK2A and CNK3B contain a domain named
conserved region among chordate (CRAC), which interacts with
coiled-coil motifs [28,30]. Moreover, CNK3B exhibits a serine-rich
region. CNK2A carries the PDZ domain ligand sequence Glu–Thr–His–
Val. Another speciﬁc feature exists in Drosophila CNK, which contains
a Raf-inhibitory (RIR) region [28] .Binding of several signaling molecules could be attributed to
speciﬁc CNK domains. SAM domains exert protein–protein interac-
tions by homo- or heterodimerization [31]. SAM domains of CNK
and Hyphen/Aveugle (HYP/Ave) heterodimerize and promote Ras-
dependent Raf activation in Drosophila [32–34]. Moreover, CNK1 binds
via SAM to the angiotensin II type 2 (AT2) receptor, even though the
receptor lacks a SAM domain [35]. The CNK-speciﬁc CRIC domain is
supposed to fold like an amphipathic helix and interacts with the AT2
receptor, Rhophilin and mixed-lineage protein kinase 2 (MLK2) [35–
37]. PDZ domains preferentially bind to very C-terminal motifs,
although interaction with internal ligands, dimerization with other
PDZ domains and binding to lipids were also reported [38]. The PDZ
domains of CNK proteins are well conserved among species, except
the insertion of a highly charged stretch of seven amino acids
immediately after the βE strand in CNK1 (Fritz and Radziwill,
unpublished observation). Despite conducted screening efforts, no
ligand for CNK's PDZ domain could be identiﬁed so far ([39]; G.
Radziwill, data not shown). In general, PH domains bind both
proteins and phospholipids [40,41]. CNK clearly localizes to the
plasma membrane in a PH domain-dependent manner [39,42].
Several reports have shown that PH domain-containing proteins
require small GTPases for proper localization to membranes [43,44].
In line with this, the small GTPases RhoA and RhoC bind to the PH
domain of CNK1 and may serve as a auxiliary factor to target CNK1
to the plasma membrane [36,45]. Whether CNK's PH domain can
associate with phospholipids or not remains debatable, since both
cases have been reported [30,36,46,47]. The CRAC domain associates
with cytohesins, which are guanine nucleotide exchange factors for Arf
GTPases [30,48]. Polyproline sequences serve as docking sites for Src
homology 3 (SH3), WW (named for a conserved Trp–Trp motif),
Enabled/VASP homology 1 (EVH1) and GYF (glycine, tyrosine,
phenylalanine motif) domains [49]. CNK1 and CNK2 have potential
binding sites for SH3 domains of the tyrosine kinase Src and the
adaptor protein Grb2, however till now, no interaction partners have
been identiﬁed.
Mammalian CNK homologs differ in their expression proﬁles.
CNK1 is expressed in various epithelial cells including breast, cervix,
colon and kidney cells [26,27,36,50,51], whereas CNK2 expression is
restricted to neuronal cells [39]. CNK3B is expressed in various tissues,
except heart and muscle [30] and nothing is known about CNK3A
tissue distribution to date.
4.2. CNK1 as regulator of signaling pathways
Generally, invertebrate CNK homologs regulate Raf kinase activa-
tion within the mitogen-activated protein kinase (MAPK) module
[28,32–34,52–54]. In contrast, mammalian CNK proteins expanded
their functional repertoire beyond Raf regulation. In fact, they are
tightly associated with (i) regulation of both the extracellular-
regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) MAPK
modules, (ii) control of various small GTPases, (iii) regulation of the
PI3K/Akt pathway, (iv) regulation of the NFκB-pathway, and (v)
signal transduction resulting in apoptosis (Fig. 3).
4.3. Activation of ERK and JNK MAPK modules by mammalian CNK
proteins
CNK2, the human homolog most resembling Drosophila CNK,
modulates the Raf–MEK–ERK pathway in neuronal cells. CNK2 binds
to Raf-1 and B-Raf proteins in overexpression system as well as in rat
crude synaptomal extract [55,56]. Downregulation of CNK2 by siRNA
inhibits nerve growth factor (NGF)-induced ERK phosphorylation and
neurite formation in PC12 cells [57]. The requirement of CNK2 for ERK
phosphorylation/activation depends on the stimulus because CNK2
knockdown has no effect on epidermal growth factor (EGF)-
dependent ERK phosphorylation. CNK1 shows a similar behavior
Fig. 2. Schematic depiction of CNK proteins. Human CNK as well as homologs from D. melanogaster and C. elegans are shown. Numbers to the right indicate protein length in amino
acids (aa).
1974 R.D. Fritz, G. Radziwill / Biochimica et Biophysica Acta 1813 (2011) 1971–1977regarding ERK activation. As CNK2, CNK1 does also bind to Raf-1 and
B-Raf [51]. CNK1 binds B-Raf constitutively, whereas the interaction
between CNK1 and Raf-1 requires stimulation of cells, e.g. by
oncogenic Ras. Moreover, CNK1 binds to the tyrosine kinase Src and
forms a trimeric complex containing CNK1, Raf-1 and Src, thereby
mediating Src-dependent Raf-1 phosphorylation that is required for
full activation of Raf-1 [51]. CNK1 downregulation does not interfere
with ERK activation upon stimulation with EGF or basic ﬁbroblast
growth factor (bFGF) [51,57]. Instead, CNK1 mediates the vascular
endothelial growth factor (VEGF)-dependent, Src-mediated Raf
phosphorylation and subsequent ERK activation [51]. Therefore,
human CNK homologs affect ERK activity only under speciﬁc
conditions, whereas Drosophila CNK is a universal ERK regulator
downstream of various receptor tyrosine kinases. Besides this, CNK1 is
also required as a scaffold for proper signal transmission in the JNK
MAPK pathway. CNK1 interacts with MLK2, MLK3 and MAPK kinase 7
(MKK7) resulting in JNK activation [37]. CNK1 downregulation
inhibits JNK activity, JNK-dependent c-Jun phosphorylation and
gene expression from the serum response element (SRE). Thus,
CNK1 is a crucial scaffold in ERK and JNK MAPK signaling.
4.4. Regulation of small GTPases by mammalian CNK homologs
CNK1, CNK2A/B and CNK3B have been found to associate with
small GTPases. CNK1 binds to the activated GTP-bound form of RhoA
and RhoC in a PH domain-dependent manner [45,55]. Moreover,CNK1 interacts with two Rho guanine nucleotide exchange factors
(GEFs), namely Net1 and p115RhoGEF [37] and with the Rho effector
Rhophilin [36]. CNK1 controls signaling speciﬁcity downstream of Rho
since CNK1 regulates gene expression from the SRE but not Rho-
dependent stress ﬁber formation. CNK2 interacts with the small
GTPase Ral and the two Ral GEFs Rlf and RalGDS, but a biological
function of these interactions could not be demonstrated [55]. CNK3B
binds to the coiled-coil regions of Cytohesin 1, 2, 3 and 4, which are
GEFs for the ADP-ribosylation factor (Arf) family of small GTPases, and
augments Cytohesin-dependent activation of Arf in vitro and in vivo
[30,47]. In addition, CNK1 has been found to interact with Cytohesins,
and by this, to be connected to insulin signaling [48].
4.5. CNK1 and FoxO in insulin signaling and proliferation
The insulin/IGF-1 pathway regulates protein synthesis, glucose
metabolism, cellular proliferation and differentiation. Insulin/IGF-1
induces Akt-dependent phosphorylation of FoxO proteins and their
sequestration in the cytoplasm. Impaired insulin/IGF-1 signaling
fosters the translocation of FoxO proteins to the nucleus where they
activate the expression of anti-proliferative target genes. FoxO
proteins are critical modulators of insulin/IGF-1 signaling, e.g.
regulation of gluconeogenesis, a key step whose dysregulation
accounts for progression of insulin resistance towards overt diabetes
[58]. Growth hormone (GH) stimulates the expression of IGF-1 and
deﬁciency in GH/IGF-1 signaling results in dwarﬁsm correlating with
Fig. 3. CNK1 regulates multiple pathways controlling FoxO activity. FoxO is
phosphorylated by the four protein kinases Akt, IKKβ, JNK and MST1. Akt- and IKKβ-
mediated phosphorylation results in FoxO inactivation and subsequent proliferation as
well as tumorigenesis, whereas JNK- and MST1-dependent phosphorylation leads to
FoxO activation and the expression of pro-apoptotic genes. CNK1 modulates Akt
activity either directly or through the regulation of its upstream activators Cytohesins.
Besides, CNK1 is a critical mediator of JNK activation and JNK-dependent signaling. In
addition, CNK1 also participates in MST1-induced apoptosis. For details see text.
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targets downstream of insulin/IGF-1 signaling regulating important
biological processes such as metabolism and life span.
Recently, the scaffold CNK1was identiﬁed as a positive regulator of
insulin signaling [48]. CNK1 constitutively interacts via its C-terminal
region with the coiled-coil region of cytohesin 1, 2, and 3. This
interaction was not altered by insulin stimulation. CNK1 was found
exclusively in the cytoplasm in serum-starved cells, whereas a portion
of CNK1 was found in the membrane fraction in insulin-treated cells.
Thereby, CNK1 facilitates membrane recruitment of cytohesins upon
insulin stimulation. Membrane-targeted cytohesins activate Arf1 and
Arf6, which function as allosteric activators of phosphatidylinositol 4-
phosphate 5-kinases (PIP5Ks) generating phosphatidylinositol 4,5-
bisphosphate (PIP2). PIP2 is critical for insulin receptor substrate 1
(IRS1) plasma membrane recruitment and acts as a lipid second
messenger and substrate of PI3K. Activated PI3K generates phospha-
tidylinositol 3,4,5-trisphosphate (PIP3), which induces the activation
of Akt. Since FoxO proteins are substrates of Akt, CNK1 may be
involved in FoxO regulation.
The CNK1/cytohesin interaction is critical for activation of the
PI3K/Akt module downstream of insulin and IGF-1 receptors.
Consistent with the known function of insulin/IGF-1 in proliferation,
CNK1 stimulates the proliferation of human embryonic kidney cells
and breast cancer cells [27]. This stimulatory effect depends on a
functional PI3K pathway. CNK1 interacts with the PI3K effector Akt
and controls Akt-dependent phosphorylation and cytoplasmic se-
questration of FoxO. Forced expression of CNK1 almost completely
inhibited FoxO1 transcriptional activity, whereas forced expression of
FoxO1 inhibited CNK1-induced proliferation.
Akt fosters proliferation through the inhibitory phosphorylation of
various anti-proliferative regulators such as FoxO and the glycogen
synthase kinase (GSK3) [60]. Although CNK1 regulates FoxO phos-
phorylation, CNK1 does not affect GSK3 phosphorylation, suggesting
that (i) GSK3/β-catenin signaling is not inﬂuenced by CNK1 and
(ii) CNK1 affects only a subset of Akt targets, at least in breast cancer
cells [27].
Interestingly, CNK1 knockdown decreased FoxO1 and FoxO3a
phosphorylation at Thr24 and Ser32, respectively, however, not at
Ser256 and Ser253. Discrimination between Thr24/Ser32 and Ser256/
Ser253 phosphorylation is attributed to the stress-activated proteinkinase (SAPK) interaction protein 1 (SIN1), a key subunit of the
mammalian target of rapamycin complex 2 (mTORC2)/PDK2, which
positively controls Akt phosphorylation on Ser473 leading to full Akt
activation [61]. 3-Phosphoinositide-dependent protein kinase 1
(PDK1)-dependent Thr308 phosphorylation that is a prerequisite for
Ser473 phosphorylation activates Akt in a manner that is sufﬁcient to
phosphorylate other targets such as GSK3 and TSC2 [61].
While a direct interaction of CNK1 with activated Akt was
identiﬁed, it is still an open question whether FoxO is part of this
complex. In insulin-stimulated cells CNK1 is recruited to the plasma
membrane [48]. In line with this, CNK1 localized predominantly to the
plasma membrane in breast cancer cells compared to untransformed
breast epithelial cells, where CNK1 is located in the cytoplasm [27].
Targeting of FoxO proteins to the plasma membrane would be a novel
sequestration mechanism for mammalians resembling the recruit-
ment of FoxO to the plasma membrane by Melted in Drosophila.
Melted interacts with and recruits FoxO and Tsc1 to the plasma
membrane bringing them in close proximity to activated Akt [62]. This
complex formation coordinates two pathways: on the one hand it
inactivates FoxO activity, on the other hand is activates the TOR
pathway involved in cell growth.
4.6. Apoptotic signaling mediated by FoxO and CNK1
FoxO proteins are actively involved in promoting apoptosis by
inducing the expression of death receptor ligands and pro-apoptotic
Bcl-2 family members such as BIM [5,63]. Both MST1 and JNK are
activated in stress-induced apoptosis and transmit the signal to FoxO
proteins. MST1 is the sensor for oxidative stress, which promotes
neuronal cell death [12,64]. MST1-induced phosphorylation of FoxO1
at Ser212 (Ser207 in FoxO3) disrupts the interaction of FoxO with
14-3-3 proteins in the cytoplasm. Accordingly, MST1 mediates
nuclear translocation of FoxO1 and expression of the pro-apoptotic
FoxO target gene BIM [12]. Stress induced by the disruption of the
cytoskeleton activates MST1, which subsequently stimulates JNK [11].
Thus, two pro-apoptotic kinases, MST and JNK, may phosphorylate
FoxO proteins and support FoxO-dependent apoptosis.
FoxO-dependent apoptosis may be linked through MST1 to the
scaffold CNK1 (Fig. 3). Prolonged overexpression of CNK1 has been
reported to induce apoptosis [50]. This effect is mediated by the tumor
suppressor Ras-association domain family 1A (RASSF1A), which
directly interacts with CNK1 and MST1 and allows MST1-dependent
apoptosis. Thus, CNK1-induced apoptosis is mediated by MST1, the
pro-apoptotic kinase, which also positively controls FoxO activity.
CNK1 localizes to the plasma membrane in mitogenic signaling [48].
The pro-apoptotic function of CNK1 may depend on a shift from the
cytoplasm to the nucleus, the compartment of active FoxO proteins.
There, CNK1 may bridge FoxO with MST1 and thereby support the
expression of pro-apoptotic genes. In addition, CNK1 may be required
for the activating phosphorylation of FoxO by JNK. Although CNK1
does not directly interact with JNK, it regulates JNK activation by the
upstream kinases MLK2/3 and MKK7 [37].
5. Conclusions
The scaffold CNK1 is required in several pathways regulating FoxO
activity (Fig. 3). While the functional relationship between CNK1 and
FoxO is proven, the physical interaction is still elusive. Both CNK1 and
FoxO are critical players in tumorigenesis although in opposite
directions, meaning that CNK1 functions as an oncoprotein, whereas
FoxO acts as a tumor suppressor [26,27,65]. Both proteins can be used
as tumor markers. Cytoplasmic localized FoxO correlates with poor
prognosis in breast cancer [66] and enrichment of plasma membrane-
localized CNK1 is found in invasive breast cancer as well as in ductal
carcinoma in situ compared to non-transformed breast epithelial
tissue [27]. Molecules interrupting the CNK1/FoxO axis would be a
1976 R.D. Fritz, G. Radziwill / Biochimica et Biophysica Acta 1813 (2011) 1971–1977possibility to block oncogenic pathways by releasing FoxO from its
cytoplasmic sequestration. In the nucleus FoxO may then exert its
function as a tumor suppressor.References
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